Biohaven Acquires Global Rights for Dual TYK2/JAK1 Inhibitor BHV-8000 from Highlightll
US-based Biohaven Ltd. (NYSE: BHVN) has announced the acquisition of global rights, excluding China regions,...
Deals
Merck & Peking University Launch Public Health Training Projects for Young and Middle-Aged Talent
Merck, Sharp & Dohme Inc. (MSD, NYSE: MRK) and the Peking University School of Public...
Smith & Nephew Partners with MedMotion for Digital Health Innovation
UK-based Smith & Nephew Plc has announced a strategic partnership with China’s Shanghai Fudong Medical...
Aidea Pharma and China Meheco Partner to Expand Medical and Pharmaceutical Services
China-based Jiangsu Aidea Pharmaceutical Co., Ltd (SHA: 688488) has announced a partnership with China Meheco...
Joincare Pharmaceutical Acquires Rights to TaiGen’s PA Endonuclease Inhibitor TG-1000
China-based Joincare Pharmaceutical Group Industry Co., Ltd (SHA: 600380) has announced a licensing agreement with...
Sinopharm Forms Joint Ventures with Foreign Medical Equipment Firms
Sinopharm China National Biotech Group Co., Ltd (CNBG) has announced partnerships with two foreign medical...
Roche Partners with China Resource Medicine to Promote Xofluza in China
Swiss pharmaceutical giant Roche (SWX: ROG) has entered into a partnership with China-based China Resource...
Jacobio Pharma Partners with Merck to Evaluate CD73 mAb and Keytruda Combination
China-based Jacobio Pharma (HKG: 1167) has announced a clinical partnership with Merck, Sharp & Dohme...
BioNTech Acquires Global Rights to OncoC4’s Anti-CTLA-4 Antibody ONC-392
Germany-based mRNA specialist BioNTech SE (NASDAQ: BNTX) has unveiled a licensing deal and collaboration with...
Cygnus Bio Raises Millions in Series C+ Financing for Sequencing Technology
Beijing-based second-generation sequencing technology platform Cygnus Bio has reportedly raised “hundreds of millions” of renminbi...
L&L Biopharma Completes Series B Financing for Tumor Immunotherapy Development
Shanghai-based tumor immunotherapy developer L&L Biopharma Co., Ltd has announced the completion of a Series...
T&L Biotechnology Secures RMB 100 Million in Series A Financing
Beijing-based cell and gene therapy (CGT) developer T&L Biotechnology Co., Ltd has reportedly raised RMB...
LBX Pharmacy Partners with Gilead Sciences to Enhance Disease Management in China
China-based LBX Pharmacy has entered into a partnership with US-based Gilead Sciences, Inc (NASDAQ: GILD)....
BeiGene Declines Option for Leap Therapeutics’ DKN-01 Development Rights in Asia
US-based Leap Therapeutics Inc. (NASDAQ: LPTX) announced last week that China-based BeiGene Ltd. (HKG: 6160,...
Gracell Secures Non-Exclusive License for Cell Therapies from Seagen
China-based Gracell Biotechnologies Inc. (Nasdaq: GRCL) has secured a non-exclusive worldwide license to develop and...
Vas Healthcare Raises RMB 100 Million in Angel Financing for Robot Development
Vas Healthcare, a developer of vascular interventional surgery robots based in Beijing, has reportedly raised...
Asiflyer Bio Raises Millions in Pre-Series A Funding for Botox and ZFP Technology
Shanghai-based recombinant protein drug developer Asiflyer Bio has reportedly raised “tens of millions” of renminbi...
Enlight Medical Technologies to Acquire Synexmed, Expand Vascular Intervention Capabilities
China-based Enlight Medical Technologies (Shanghai) Co., Ltd is set to fully acquire Japanese firm Japan...
Bochuang Biotechnology Secures Angel Funding for High-Purity Collagen and Innovative Medical Product Development
Jiangsu Bochuang Biotechnology Co., Ltd reportedly secured an undisclosed amount of funding in an angel...
Terumo Blood and Cell Technologies Partners with EurekaBio to Establish Cell Therapy Lab
US-based Terumo Blood and Cell Technologies has entered into a partnership with Shenzhen-headquartered EurekaBio Technology...